• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于患者的卫生技术评估:未来展望

Patient-based health technology assessment: a vision of the future.

作者信息

Bridges John F P, Jones Christopher

机构信息

Health Policy and Management, Johns Hopkins Bloomberg School of Public Health, 624 North Broadway, Baltimore, MD 21205, USA.

出版信息

Int J Technol Assess Health Care. 2007 Winter;23(1):30-5. doi: 10.1017/S0266462307051549.

DOI:10.1017/S0266462307051549
PMID:17234014
Abstract

BACKGROUND

In conjunction with other important movements in contemporary medicine, including evidence-based medicine (EBM), health technology assessment (HTA) has promoted a culture of critical evaluation. Despite this impact, institutional and methodological challenges are associated with HTA. For example, only in recent years has HTA attempted an open dialogue with patients; however, this is normally done by giving them a "seat" at the HTA decision-making table, rather than by more scientific means.

OBJECTIVES

The aim of this study was to develop a working definition of patient-based HTA, to identify the current barriers to adopting a patient-based model, and to formulate a vision of how a patient-based HTA could be used to promote patient empowerment and patient-centered care.

RESULTS

In the ideal setting, a patient-based HTA would promote patient knowledge by providing access to information and promoting an informed dialogue between patients and their healthcare professionals. To implement a patient-based HTA, the focus must turn to the patient's issues and incorporate each patient's unique perspective and preferences. Processes must change to increase patient participation in all levels of HTA and aim to promote empowered patients who can make informed decisions.

CONCLUSIONS

Present-day HTA is broad and has numerous stakeholders, with none so important as the patient. By asking patient-oriented questions in HTA and better involving patients throughout the entire process, we can easily promote patient empowerment, and as such make patients more capable to play a more active role in healthcare decision making.

摘要

背景

与当代医学中的其他重要运动(包括循证医学)相结合,卫生技术评估(HTA)促进了批判性评估的文化。尽管有这种影响,但HTA仍面临机构和方法上的挑战。例如,直到最近几年HTA才尝试与患者进行公开对话;然而,这通常是通过在HTA决策桌上给他们一个“席位”来实现的,而不是通过更科学的方式。

目的

本研究的目的是制定基于患者的HTA的实用定义,确定采用基于患者的模式的当前障碍,并构想如何利用基于患者的HTA来促进患者赋权和以患者为中心的护理。

结果

在理想情况下,基于患者的HTA将通过提供信息获取渠道并促进患者与其医疗保健专业人员之间的明智对话来提高患者知识水平。要实施基于患者的HTA,重点必须转向患者的问题,并纳入每个患者的独特观点和偏好。流程必须改变,以增加患者在HTA各级的参与度,并旨在促进能够做出明智决策的赋权患者。

结论

当今的HTA范围广泛,有众多利益相关者,其中没有一个比患者更重要。通过在HTA中提出以患者为导向的问题并在整个过程中更好地让患者参与,我们可以轻松促进患者赋权,从而使患者更有能力在医疗保健决策中发挥更积极的作用。

相似文献

1
Patient-based health technology assessment: a vision of the future.基于患者的卫生技术评估:未来展望
Int J Technol Assess Health Care. 2007 Winter;23(1):30-5. doi: 10.1017/S0266462307051549.
2
Avoiding and identifying errors in health technology assessment models: qualitative study and methodological review.避免和识别健康技术评估模型中的错误:定性研究和方法学综述。
Health Technol Assess. 2010 May;14(25):iii-iv, ix-xii, 1-107. doi: 10.3310/hta14250.
3
Use of health technology assessment in decision making: coresponsibility of users and producers?卫生技术评估在决策中的应用:使用者与生产者的共同责任?
Int J Technol Assess Health Care. 2005 Spring;21(2):268-75.
4
Health technology assessment-based development of a Spanish breast cancer patient decision aid.基于卫生技术评估的西班牙乳腺癌患者决策辅助工具的开发。
Int J Technol Assess Health Care. 2011 Oct;27(4):363-8. doi: 10.1017/S0266462311000493.
5
[Experiences with and impact of health technology assessment on the German Standing Committee of physicians and patients].[卫生技术评估对德国医师与患者常设委员会的影响及相关经验]
Z Arztl Fortbild Qualitatssich. 2002 Feb;96(2):82-90.
6
Using health technology assessment to support evidence-based decision-making in Canada: an academic perspective.利用健康技术评估支持加拿大循证决策:学术视角。
Expert Rev Pharmacoecon Outcomes Res. 2011 Oct;11(5):513-21. doi: 10.1586/erp.11.60.
7
Development and implementation of health technology assessment in Argentina: two steps forward and one step back.阿根廷卫生技术评估的发展与实施:前进两步,后退一步。
Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:260-9. doi: 10.1017/S0266462309090734. Epub 2009 Jun 16.
8
Organizational and patient-related assessments in HTAs: state of the art.卫生技术评估中的组织和患者评估:最新进展。
Int J Technol Assess Health Care. 2009 Oct;25(4):530-6. doi: 10.1017/S0266462309990456.
9
A short history of health technology assessment in Germany.德国卫生技术评估简史。
Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:112-9. doi: 10.1017/S0266462309090515. Epub 2009 Jun 8.
10
History of health technology assessment: Spain.卫生技术评估史:西班牙
Int J Technol Assess Health Care. 2009 Jul;25 Suppl 1:163-73. doi: 10.1017/S026646230909059X. Epub 2009 Jun 19.

引用本文的文献

1
Shared decision-making endorses intention to follow through treatment or vaccination recommendations: a multi-method survey study among older adults.共同决策支持遵循治疗或疫苗接种建议的意向:一项针对老年人的多方法调查研究。
BMC Med Inform Decis Mak. 2024 Jul 23;24(1):202. doi: 10.1186/s12911-024-02611-2.
2
Towards conceptualizing patients as partners in health systems: a systematic review and descriptive synthesis.将患者概念化为卫生系统的合作伙伴:系统评价和描述性综合。
Health Res Policy Syst. 2023 Jan 25;21(1):12. doi: 10.1186/s12961-022-00954-8.
3
High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation.
大剂量化疗联合干细胞解救治疗 III 期同源缺陷型乳腺癌:影响临床实施的因素。
BMC Cancer. 2023 Jan 7;23(1):26. doi: 10.1186/s12885-022-10412-x.
4
Investigating patients' preferences for new anti-diabetic drugs to inform public health insurance coverage decisions: a discrete choice experiment in China.调查患者对新型抗糖尿病药物的偏好,为公共医疗保险覆盖决策提供信息:在中国进行的一项离散选择实验。
BMC Public Health. 2022 Oct 5;22(1):1860. doi: 10.1186/s12889-022-14244-z.
5
Potential Barriers of Patient Involvement in Health Technology Assessment in Central and Eastern European Countries.中东欧国家中患者参与健康技术评估的潜在障碍。
Front Public Health. 2022 Jul 28;10:922708. doi: 10.3389/fpubh.2022.922708. eCollection 2022.
6
Information Patients With Melanoma Spontaneously Report About Health-Related Quality of Life on Web-Based Forums: Case Study.信息 黑素瘤患者在基于网络的论坛上自发报告的与健康相关的生活质量:案例研究。
J Med Internet Res. 2021 Dec 7;23(12):e27497. doi: 10.2196/27497.
7
Health Technology Assessment Development in Vietnam: A Qualitative Study of Current Progress, Barriers, Facilitators, and Future Strategies.越南卫生技术评估发展:当前进展、障碍、促进因素和未来战略的定性研究。
Int J Environ Res Public Health. 2021 Aug 22;18(16):8846. doi: 10.3390/ijerph18168846.
8
Patient engagement in health technology assessment (HTA) and the regulatory process: what about rheumatology?患者参与卫生技术评估(HTA)及监管过程:风湿病领域情况如何?
RMD Open. 2020 Nov;6(3). doi: 10.1136/rmdopen-2020-001286.
9
Psychological aspects of atrial fibrillation: A systematic narrative review : Impact on incidence, cognition, prognosis, and symptom perception.心房颤动的心理方面:系统叙述性综述:对发生率、认知、预后和症状感知的影响。
Curr Cardiol Rep. 2020 Sep 10;22(11):137. doi: 10.1007/s11886-020-01396-w.
10
Use of Patient Preferences in Health Technology Assessment: Perspectives of Canadian, Belgian and German HTA Representatives.使用患者偏好进行卫生技术评估:加拿大、比利时和德国 HTA 代表的观点。
Patient. 2021 Jan;14(1):119-128. doi: 10.1007/s40271-020-00449-0.